Indicators
Indicators
Value
Direction
MACD(12,26,9)
-0.027
Sell
RSI(14)
22.357
Sell
STOCH(KDJ)(9,3,3)
5.985
Oversold
ATR(14)
0.033
Low Volatility
CCI(14)
-171.251
Sell
Williams %R
93.337
Oversold
TRIX(12,20)
-1.274
Sell
StochRSI(14)
0.000
Oversold
Search
BioRestorative Therapies Inc
BRTXAdd to Watchlist
0.206USD
-0.020-8.78%
Close 07-31 16:00（ET）Quotes delayed by 15 min
5.24MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-8.78%
5 Days
-29.07%
1 Month
-45.29%
6 Months
-81.96%
Year to Date
-82.49%
1 Year
-86.01%
Key Figures
0.229Open
0.236High
929.29KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
3.65%Turnover Ratio
0.226Prev. Close
0.193Low
133.96KTurnover
LossP/E Static
1.73P/B
0.00%Div Yield TTM
-147.75%ROA
2.04552wk High
1.60Volume Ratio
-8.98MNet Profit
25.48MShares
-1.0662EPS TTM
0.50Beta
-241.50%ROE
0.15952wk Low
19.07%Amplitude
68.13%Gross Margin
5.24MMarket Cap
-7.00Reward/Risk
6.24%Risk Rate
TradingKey Stock Score of BioRestorative Therapies Inc
Currency: USD Updated: 2026-07-31Key Insights
BioRestorative Therapies Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 85 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 8.00.In the medium term, the stock price is expected to trend down.Despite a very weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
BioRestorative Therapies Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Positive
BioRestorative Therapies Inc Highlights
StrengthsRisks
BioRestorative Therapies, Inc. is engaged in developing therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. It has commenced a Phase II clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The Company is engaged in developing a cell-based therapy candidate, ThermoStem Program, which targets obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). It has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. It also operates a commercial biocosmeceutical platform.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 146.71% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 359.70K.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 359.70K.
Overvalued
The company’s latest PE is -0.19, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 1.24M shares, decreasing 15.25% quarter-over-quarter.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.88.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
8.000
Target Price
+3137.56%
Upside Space
BioRestorative Therapies Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
2
analysts
Buy
Current Rating
8.000
Target Price
+3137.56%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
BioRestorative Therapies Inc
BRTX
2
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
0.244
Sell
MA10
0.278
Sell
MA20
0.314
Sell
MA50
0.346
Sell
MA100
0.297
Sell
MA200
0.677
Sell
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
BioRestorative Therapies Inc Info
BioRestorative Therapies, Inc. is engaged in developing therapeutic products using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. It has commenced a Phase II clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease. The Company is engaged in developing a cell-based therapy candidate, ThermoStem Program, which targets obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). It has also licensed an investigational curved needle device designed to deliver cells and/or other therapeutic products or material to the spine and discs. It also operates a commercial biocosmeceutical platform.
Ticker SymbolBRTX
CompanyBioRestorative Therapies Inc
CEOAlstodt (Lance)
Websitehttps://www.biorestorative.com/
Shareholders
Related Instruments
-0.53%
+0.23%
-1.00%
-2.54%
+0.33%
-1.44%
-0.61%
-0.79%
-8.78%
+0.48%
+0.70%
-1.00%
-0.69%
+0.49%
-1.08%
+3.32%
0.00%
+1.34%
-0.87%
-2.17%Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of BioRestorative Therapies Inc (BRTX)?
The current price of BioRestorative Therapies Inc (BRTX) is 0.21.
What is the symbol of BioRestorative Therapies Inc?
The ticker symbol of BioRestorative Therapies Inc is BRTX.
What is the 52-week high of BioRestorative Therapies Inc?
The 52-week high of BioRestorative Therapies Inc is 2.04.
What is the 52-week low of BioRestorative Therapies Inc?
The 52-week low of BioRestorative Therapies Inc is 0.16.
What is the market capitalization of BioRestorative Therapies Inc?
The market capitalization of BioRestorative Therapies Inc is 5.24M.
Is BioRestorative Therapies Inc (BRTX) currently rated as Buy, Hold, or Sell?
According to analysts, BioRestorative Therapies Inc (BRTX) has an overall rating of Buy, with a price target of 8.00.
What is the Earnings Per Share (EPS TTM) of BioRestorative Therapies Inc (BRTX)?
The Earnings Per Share (EPS TTM) of BioRestorative Therapies Inc (BRTX) is -1.58.